Researchers at UBC’s faculty of medicine and BC Cancer, in partnership with BC Children’s Hospital…
pthomsonNovember 3, 2021
Twice a year entrepreneurship@UBC recruits a cohort of research-based venture teams ready to translate their…
pthomsonNovember 2, 2021
Dr. Jacobson’s and Dr. Vallance’s labs are focusing on the role of the epithelial barrier…
pthomsonNovember 2, 2021
Dr. Anna Blakney (pictured), an Assistant Professor at UBC, was awarded a Canadian Institutes of…
pthomsonNovember 1, 2021
NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a clinical stage biotech…
pthomsonNovember 1, 2021
It has been a prolific quarter for TFRI’s BC-based lymphoma research team. In the span…
pthomsonOctober 29, 2021
TFRI-funded researchers at BC Cancer in a new study demonstrate that a genomic test known…
pthomsonOctober 28, 2021
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) designed to “reboot” the…
sciencecityJune 1, 2017
A clinical trial for a type of brain stimulation therapy is underway at Surrey Memorial…
sciencecityMay 30, 2017
New medicines are no longer one-size-fits-all. Therapies are more complex, manufactured in smaller batches and…
sciencecityMay 29, 2017
“Think of a multiple sclerosis lesion as the tip of the iceberg,” says Dr. Alex…
sciencecityMay 26, 2017
In one of the most comprehensive studies to date, UBC researchers have identified potential adverse…
sciencecityMay 25, 2017
Researchers investigating genetically predisposed or at-risk individuals and their families affected by early onset cardiovascular…
sciencecityMay 24, 2017
MSFHR has announced 11 award recipients for its inaugural Health Professional-Investigator Program. These exceptional health…
sciencecityMay 23, 2017
Vancouver virtual life sciences company Novelogics Biotechnology Inc. has partnered with the Centre for Drug…
sciencecityMay 23, 2017
